Blood Test That Detects Changes in Tumor DNA Predicts Survival in Advanced Disease February 28, 2017Vol.40 No.02
Durvalumab Shows Activity in Patients who Progressed on Platinum-Based Chemo February 28, 2017Vol.40 No.02
Drugs & Targets FDA Approves Opdivo for Urothelial Carcinoma Indication February 28, 2017Vol.40 No.02
Opdivo Demonstrated Improved Survival in Advanced Gastric Cancer in Phase III Study February 28, 2017Vol.40 No.02
Drugs & Targets FDA approves marketing of 23andMe’s Bloom Syndrome carrier test February 27, 2017Vol.41 No.08
Funding Opportunities PCRP announces research awards application guidelines February 17, 2017Vol.43 No.07
Drugs & Targets Amgen submits Supplemental Biologics License Application for Blincyto February 17, 2017Vol.43 No.07
